GlassScriptPhysician profile
Brent W Walters
NPI 1891855425
$1,918.88
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,648 · 2020: $254 · 2021: $17.60.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $529.79 | 2019-2021 | |
| Abbvie INC. | $197.96 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $169.04 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $145.29 | 2019-2020 | |
| Ucb, INC. | $113.81 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.17 | 2019-2020 | |
| Glaxosmithkline, LLC. | $74.53 | 2019-2020 | |
| Pfizer INC. | $71.44 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $69.39 | 2019-2020 | |
| Lilly USA, LLC | $64.15 | 2019 | |
| Novo Nordisk INC | $61.02 | 2019-2020 | |
| Janssen Biotech, INC. | $48.75 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.57 | 2019 | |
| Pacira Therapeutics, INC. | $40.82 | 2019 | |
| Radius Health, INC. | $40.78 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.13 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $25.74 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $22.80 | 2019 | |
| Astellas Pharma US INC | $22.32 | 2019 | |
| Nevro Corp. | $16.74 | 2020 | |
| Horizon Therapeutics Plc | $15.48 | 2019 | |
| Sanofi Pasteur INC. | $13.16 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.